Green Thumb Industries (GTII) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
3 Feb, 2026Executive summary
Q2 2025 revenue reached $293.3 million, up 4.7% year-over-year, driven by CPG sales and adult-use market expansion in New York and Ohio.
Adjusted EBITDA was $83 million (28% margin), with $56 million in operating cash flow.
GAAP net loss was $0.65 million ($0.01/share); excluding a one-time $11.7 million asset sale loss, net income was $11 million ($0.05/share).
Repurchased 5.6 million shares for $24 million during the quarter.
Strategic investments in THC beverages and partnerships, including AgriPi Corporation, are expanding product offerings and market reach.
Financial highlights
Gross profit was $146.3 million (49.9% margin), down from $150.5 million (53.7%) year-over-year due to price compression.
Retail revenue increased 0.3% year-over-year; comparable store sales declined 4.1%.
CPG net revenue rose 17% year-over-year; CPG gross revenue up 8.4%.
SG&A expenses were $107 million (36% of revenue), up from $97 million (34%) last year.
Adjusted EBITDA was $83 million, down from $94 million year-over-year.
Outlook and guidance
Q3 revenue expected to be flat to down low single digits sequentially, assuming no adult use launch in Minnesota.
Margins and adjusted EBITDA anticipated to remain below 30% due to ongoing pricing challenges.
Management remains confident in strategy and financial strength to navigate current market conditions.
Cautious near-term outlook due to price compression, regulatory uncertainty, and macroeconomic pressures.
Latest events from Green Thumb Industries
- Market leader in THC with strong brands, financials, and growth from regulatory tailwinds.GTII
Investor presentation - Q2 revenue up 5% to $307M, strong cash flow, and robust share buybacks amid regulatory progress.GTII
Q2 2026 - All proposals passed, with strong financials and strategic focus on regulatory and brand growth.GTII
AGM 2026 - Cannabis market growth and brand leadership drive strong financial results and national expansion.GTII
Investor presentation - Cannabis market growth and brand leadership drive robust revenue and EBITDA performance.GTII
Investor presentation - Q1 2026 revenue up 7.5% to $300.2M, strong cash flow, and expanded share buybacks.GTII
Q1 2026 - Revenue rose 3.4% in 2025, with strong cash flow and retail expansion offset by margin pressure.GTII
Q4 2025 - Q3 revenue up 4% to $287M, Adjusted EBITDA margin 31.1%, strong cash flow and liquidity.GTII
Q3 2024 - Revenue up 1.4% to $280M, but net income and margins declined amid price compression.GTII
Q1 2025